Transcript Ireland`s experience - United Nations Office on Drugs and Crime

NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
THE DEVELOPMENT AND TESTING OF NDS
IRELAND’ S EXPERIENCE TO DATE
Dr Lorraine Nolan
1
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
Requirement for IT Technologies to Manage the following:• Various Controlled Drug Licence Application and Issue
Processes.
• Client Files and Information.
• UN Reporting Functions.
• Frequently Asked Questions.
2
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
The Purpose of Introducing IT Based Technologies is to make the
the various business processes more efficient.
Specific Aims Are:-
• To decrease the turn around time for the licence issue process
particularly for import and export licences.
• To provide information for FAQ in an manner that is convenient
and readily accessible.
• To provide electronic methods of generating the statistical
reports for the INCB and decrease the turn around time for this
process.
• To provide better client file management.
3
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
The Development of IT Technologies has two Main
focuses:• The testing introduction and of the NDS System developed by
UNDCP.
• The development and introduction of a functionally based
Website Application.
4
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
NDS Installation and Testing
1. Hardware and Software Installation.
2. Development of Master files.
3. Testing of Functionality Aspects.
4. Import Licence/Certificate and Export Licence Templates.
5
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
NDS Installation and Testing
1. Hardware and Software Installation.
• Installation of NDS version 4.01 was completed December
2001.
• Upgrade to NDS version 4.05 was completed in September
2002.
6
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
NDS Installation and Testing
2.
Development of Master Files (i)
•
Entry of information from all nationally based company files.
Coding
EAN Coding
Additional Definitions
Type of organisation
Contact Details
Licensing/ Registration Details
7
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
NDS Installation and Testing
2.
Development of Master Files Continued (ii)
•
Entry of information for international companies.
•
Entry of national and international estimates and
assessments.
8
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
NDS Installation and Testing
2.
Development of Master Files Continued (iii)
•
Entry of Substances e.g. raw drug
Those under international control were included as part of the
installation.
Those under national control were entered into the system.
9
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
NDS Installation and Testing
2.
Development of Master Files Continued (iv)
•
Entry of Preparations: Medicinal Products, Chemical Preparations.
Every product imported or exported must be entered.
Products are assigned a unique code.
Product definitions.
10
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
NDS Installation and Testing
2.
Development of Master Files Continued (v)
Entry of Preparations: Medicinal Products, Chemical Preparations
•
Preparation Coding.
Medicinal Products are coded where appropriate in terms of the
market authorisation number.
Chemical Products are coded in terms of the Manufacturers
Product Number.
11
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
NDS Installation and Testing
2.
Development of Master Files Continued (vi)
Entry of Preparations: Medicinal Products, Chemical Preparations
•
Product Definitions
EAN Number.
Country of Export.
Content: Identification of the active and expression of its content
as anhydrous base per unit.
12
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
NDS Installation and Testing
2.
Development of Master Files Continued (vii)
Entry of Preparations: Medicinal Products, Chemical Preparations
Description:
Should be adequate to identify the product to its labelling including
details of strength/concentration and pack size/unit quantity e.g. in
the case of the following medical preparation “Morstel SR Tablets
(60mg) x 60”.
13
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
NDS Installation and Testing
3.
Testing of Functionality Aspects (i)
As part of the development process every import and export licence
issued during 2002 has been systematically entered into NDS in
conjunction with the current system. Through this the following key
issues have been examined.
•
That the system is capable of assembling and correctly
presenting all of the information required for the generation of an
import licence, import certificate and an export licence.
14
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
3.
Testing of Functionality Aspects Continued (ii).
•
The ability of the NDS to collectively compile and control the
quantities of controlled drug (expressed in terms anhydrous
base) imported and exported by Ireland during 2002.
•
The ability of the NDS to manage the national and
international estimates and assessments for controlled drugs.
•
That preparations and substances have been correctly
entered into system in terms of coding, description and
content.
•
That the information in the Master Files is correct.
15
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
3.
Testing of Functionality Aspects Continued. (iii)
The endorsement information received in respect of the import and
export licences issued during 2002 has also been entered into the
system. The Quarterly Statistical Reports for the INCB have been
automatically generated by NDS through this endorsement process
and examined.
•
This has verified that NDS is capable of accurately generating
such statistical reports, through a more efficient process
which does not require additional manual entry and transfer of
data.
16
NDS : Ireland’s Experience
5th NDS USER GROUP MEETING,OTTAWA, CANADA 10-12 March 2003
4.
Import Licence/Certificate and Export Licence Templates
Templates have to be integrated into NDS so that it is capable of
generating actual licences and certificates comparable with those
issued by current systems.
•
The UNDCP are progressing the development of the
templates.
•
The current templates are to be integrated into NDS by May
2003 at which point NDS can be used to generate our Import
Licence/Certificate and Export Licences.
•
Launch of our use of NDS is anticipated in mid 2003.
17